The Microdosimetry of Boron Neutron Capture Therapy

Total Page:16

File Type:pdf, Size:1020Kb

The Microdosimetry of Boron Neutron Capture Therapy University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 12-2008 The Microdosimetry of Boron Neutron Capture Therapy Trent L. Nichols University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Recommended Citation Nichols, Trent L., "The Microdosimetry of Boron Neutron Capture Therapy. " PhD diss., University of Tennessee, 2008. https://trace.tennessee.edu/utk_graddiss/581 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Trent L. Nichols entitled "The Microdosimetry of Boron Neutron Capture Therapy." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Physics. Soren P. Sorensen, Major Professor We have read this dissertation and recommend its acceptance: Leo. L Riedinger, Carrol R. Bingham, George W. Kabalka, Laurence F. Miller Accepted for the Council: Carolyn R. Hodges Vice Provost and Dean of the Graduate School (Original signatures are on file with official studentecor r ds.) To the Graduate Council: I am submitting herewith a dissertation written by Trent Lee Nichols entitled “The Microdosimetry of Boron Neutron Capture Therapy.” I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Physics. Soren P. Sorensen, Major Professor We have read this dissertation and recommend its acceptance: Leo. L Riedinger Carrol R. Bingham George W. Kabalka Laurence F. Miller Accepted for the Council: Carolyn R Hodges Vice Provost and Dean of the Graduate School (Original signatures are on file with official student records.) The Microdosimetry of Boron Neutron Capture Therapy A Dissertation Presented for the Doctor of Philosophy Degree The University of Tennessee Trent Lee Nichols, MD December 2008 Copyright ©, Trent Lee Nichols, M.D, Ph.D. 2008 All rights reserved ii Dedication This dissertation is dedicated to the memory of my father, Ted Nichols, whose love, support, and guidance has been so important to me. There is not a day that I do not think of him. iii Acknowledgements Earning a Ph.D. is a reflection of all the professors who have influenced and shaped one’s career. It is not possible to thank everyone who has helped me to achieve this milestone. To all who have helped in one way or another, I wish to express my gratitude but there are several however who deserve special recognition. In undergraduate and graduate school, I was fortunate to have many excellent professors. Dr. P. G. Huray, my first physics professor and major professor for my masters degree, sparked my love for physics. Dr. W. E. Deeds taught me to question everything. Drs. R. D. Present, J.R. Thompson, T. A. Callcott, and E. G. Harris taught me how to think as a physicist. Dr. R. W. Lide provided imortant perspectives on life. A special thanks to Dr. M. W. Guidry who taught me how to integrate knowledge from one area of physics and apply it in another. Dr. Guidry’s belief in my abilities has much to do with me having the confidence to pursue this degree over such a long time. He gave me the opportunity of a lifetime by helping me to go to the Niels Bohr Institutet at the Københavns Universitet in København, Denmark. In working on the problem of Boron Neutron Capture Therapy, I have met, talked, and collaborated with colleagues throughout the world. To each I owe gratitude since each has contributed to my understanding of BNCT. In particular, I would like to recognize Drs. R. G. Zamenhof, P. M. Busse, J. Capala, J. C. Yanch, D. Nigg, A. Soloway, R. Barth, G. Smith, and T. Byrnes. In particular, I wish to thank my committee: Drs. S. P. Sorensen, C. R. Bingham, G. W. Kabalka, L. F. Miller, and L. L. Riedinger for being available to help me to obtain a life long goal. Dr. Bingham has been encouraging throughout my career. His quiet optimism has been an important role model. He is always willing to stop to answer questions or provide a new insight into nuclear physics. Early in my career, Dr. Bingham taught me much about experimental nuclear physics. Without the support and encouragement of Dr. Riedinger, I would not have been able to accomplish my goal of a Ph.D. in physics. He taught me electricity and magnetism, brought me into nuclear physics research, and has believed in me. Very iv importantly, he convinced the graduate school to allow me to complete my interupted degree. Dr. Riedinger is a mentor and friend who exemplifies what it means to be a professor of physics. A special thanks to Dr. Miller whose help with the details of neutron beams and the details of the dose calculations was invaluable. He kept me focused on the tasks at hand rather than pursue interesting but unimportant avenues. His thoughts and views on the subject was an important part of this research. Without his cheerful and positive encouragement, this dissertation may have never come to fruition. An excellent mentor is essential to a graduate student. I was fortunate to have Dr. G. Kabalka as my mentor. He has taught me much about being a professional in research and in doing so he has become a close friend and confidant. We have shared research successes together as well as a few disappointments. His optimism, insights, and wisdom has been a positive influence in my life. I am a better person for having had the privilege to work with Dr. Kabalka. The culmination of a Ph.D. requires a major professor who can be critical, helpful, and encouraging all at the same time. Dr. Sorensen has provided me that guidance. He stepped in at a critical point in my research and has guided me to the completion of my degree. He has helped me to regain the critical thinking crucial to being a physicist that years of medical practice has dulled. Without his help and support, I would have likely never completed my degree. Obtaining my Ph.D. has required much sacrifice, understanding, and patience from my family. My parents, Ted and Audrey Nichols, have been supportive throughout my career. My wonderful children, Ted and Frances have long since learned that dad watches television only with a computer multi-tasking some sort of physics related project. I am so very proud of them both and I am enjoying watching their lives unfold. Most importantly of all, I wish to thank my wonderful wife Sally. Without her devotion, patience, support, and love my degree could never have been achieved. She has picked me up when I was down and has carried me through the hard times. She has helped me in every aspect of my dissertation but most importantly she encouraged me v when I was ready to quit. We have shared many good times over the past 30 years and a few bad times. Sally is the love of my life and to her I owe the most. vi Abstract Boron neutron capture therapy (BNCT) is a brachyradiotherapy that exploits the large thermal neutron (~0.025eV) cross-section of 10 B. After absorbing a neutron, a 11 B compound nucleus will spontaneously fission into an alpha particle and a lithium nucleus. An average energy of 2.31 MeV is deposited in a volume on the order of one cell diameter. The large masses and high energies of ion products constitute a high linear energy transfer (LET) reaction. High LET reactions cause double stranded deoxyribonucleic acid (ds-DNA) breaks that lead to cell death because the breaks cannot be accurately repaired. BNCT has been used in clinical trials to treat the aggressive infiltrative brain malignancy, glioblastoma multiforme, and the skin cancer, melanoma. The few studies on melanoma seem to be more promising than the trials on glioblastoma. The cellular level energy deposition pattern, the microdosimetry, reveals the reason for the observed differences. Programs were written modeling cells as ellipsoids arranged in a body centered cubic with nuclei that can be spheres or ellipsoids independent of the cell and non- concentric. The dose was calculated for various boron concentrations in the interstitium, the cell cytoplasm, and the cell nuclei for different geometries. The results demonstrate that cells closely packed receive a larger dose than widely separate cells. Also, the dose increases linearly with boron concentration so that better boron delivery agents will improve the efficacy. Infiltrative glioblastoma cells that are in small clumps or isolated receive a smaller dose than melanoma cells that are tightly packed. The microdosimetric model corresponds to clinically observed results. Also, the model predicts that improved boron delivery agents could make glioblastoma a disease that is curable by BNCT. vii Preface Cancer causes much human suffering as well as economic losses due to lost wages and the cost of therapy. Despite monumental medical efforts, cancer remains difficult to cure for many cell types. Often, treatment regimens cause considerable morbidity and occasional mortality. The treatment regimen often has connected morbidities that are significant enough to cause the patient to miss work for some time after the completion of the therapy. The search continues to find a safe, focused, efficacious radiotherapy with minimal morbidity.
Recommended publications
  • Understanding the Potentiality of Accelerator
    Bortolussi et al. Radiation Oncology (2017) 12:130 DOI 10.1186/s13014-017-0860-6 RESEARCH Open Access Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience Silva Bortolussi1,2* , Ian Postuma2, Nicoletta Protti2, Lucas Provenzano3,4, Cinzia Ferrari5,2, Laura Cansolino5,6, Paolo Dionigi5,6, Olimpio Galasso7, Giorgio Gasparini7, Saverio Altieri1,2, Shin-Ichi Miyatake8 and Sara J. González3,4 Abstract Background: Osteosarcoma is the most frequent primary malignant bone tumour, and its incidence is higher in children and adolescents, for whom it represents more than 10% of solid cancers. Despite the introduction of adjuvant and neo-adjuvant chemotherapy that markedly increased the success rate in the treatment, aggressive surgery is still needed and a considerable percentage of patients do not survive due to recurrences or early metastases. Boron Neutron Capture Therapy (BNCT), an experimental radiotherapy, was investigated as a treatment that could allow a less aggressive surgery by killing infiltrated tumour cells in the surrounding healthy tissues. BNCT requires an intense neutron beam to ensure irradiation times of the order of 1 h. In Italy, a Radio Frequency Quadrupole (RFQ) proton accelerator has been designed and constructed for BNCT, and a suitable neutron spectrum was tailored by means of Monte Carlo calculations. This paper explores the feasibility of BNCT to treat osteosarcoma using this neutron source based on accelerator. Methods: The therapeutic efficacy of BNCT was analysed evaluating the dose distribution obtained in a clinical case of femur osteosarcoma. Mixed field dosimetry was assessed with two different formalisms whose parameters were specifically derived from radiobiological experiments involving in vitro UMR-106 osteosarcoma cell survival assays and boron concentration assessments in an animal model of osteosarcoma.
    [Show full text]
  • Nuclear Data for Medical Applications ° ° INM-5: Nuklearchemie,INM-5: Forschungszentrum Germjülich, Abteilung Nuklearchemie, Zu Germanuniversitätköln, ° Syed M
    Mitglied der Helmholtz-Gemeinschaft derMitglied Nuclear Data for Medical Applications ° Syed M. Qaim ° INM-5: Nuklearchemie, Forschungszentrum Jülich, Germany; ° Abteilung Nuklearchemie, Universität zu Köln, Germany Plenary Lecture given at a Workshop in the 7 th Framework Programme of the European Union on “Solving Challenges in Nuclear Data for the Safety of Nuclear Facilities (CHANDA)”, Paul Scherrer Institute, Villigen, Switzerland, 23 to 25 November 2015 Outline ° Introduction - external radiation therapy - internal radionuclide applications ° Commonly used radionuclides - status of nuclear data - alternative routes for production of 99m Tc - standardisation of production data ° Research oriented radionuclides - non-standard positron emitters - novel therapeutic radionuclides ° New directions in radionuclide applications ° Future data needs ° Summary and conclusions Nuclear Data Research for Medical Use Aim ° Provide fundamental database for - external radiation therapy - internal radionuclide applications Areas of Work ° Experimental measurements ° Nuclear model calculations ° Standardisation and evaluation of existing data Considerable effort is invested worldwide in nuclear data research External Radiation Therapy • Biological changes under the impact of radiation • Of significance is linear energy transfer (LET) to tissue Types of Therapy • Photon therapy : use of 60 Co or linear accelerator (low-LET radiation ) most common • Fast neutron therapy : accelerator with E p or E d above 50 MeV (high-LET radiation ) being abandoned
    [Show full text]
  • Carbon Ion Therapy for Advanced Sinonasal Malignancies: Feasibility
    Jensen et al. Radiation Oncology 2011, 6:30 http://www.ro-journal.com/content/6/1/30 RESEARCH Open Access Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity Alexandra D Jensen1*, Anna V Nikoghosyan1, Swantje Ecker2, Malte Ellerbrock2, Jürgen Debus1 and Marc W Münter1 Abstract Purpose: To evaluate feasibility and toxicity of carbon ion therapy for treatment of sinonasal malignancies. First site of treatment failure in malignant tumours of the paranasal sinuses and nasal cavity is mostly in-field, local control hence calls for dose escalation which has so far been hampered by accompanying acute and late toxicity. Raster-scanned carbon ion therapy offers the advantage of sharp dose gradients promising increased dose application without increase of side-effects. Methods: Twenty-nine patients with various sinonasal malignancies were treated from 11/2009 to 08/2010. Accompanying toxicity was evaluated according to CTCAE v.4.0. Tumor response was assessed according to RECIST. Results: Seventeen patients received treatment as definitive RT, 9 for local relapse, 2 for re-irradiation. All patients had T4 tumours (median CTV1 129.5 cc, CTV2 395.8 cc), mostly originating from the maxillary sinus. Median dose was 73 GyE mostly in mixed beam technique as IMRT plus carbon ion boost. Median follow- up was 5.1 months [range: 2.4 - 10.1 months]. There were 7 cases with grade 3 toxicity (mucositis, dysphagia) but no other higher grade acute reactions; 6 patients developed grade 2 conjunctivits, no case of early visual impairment. Apart from alterations of taste, all symptoms had resolved at 8 weeks post RT.
    [Show full text]
  • Present Status of Fast Neutron Therapy Survey of the Clinical Data and of the Clinical Research Programmes
    PRESENT STATUS OF FAST NEUTRON THERAPY SURVEY OF THE CLINICAL DATA AND OF THE CLINICAL RESEARCH PROGRAMMES Andre Wambersie and Francoise Richard Universite Catholique de Louvain, Unite de Radiotherapie, Neutron- et CurietheVapie, Cliniques Universitaires St-Luc, 1200-Brussels, Belgium. Abstract The clinical results reported from the different neutron therapy centres, in USA, Europe and Asia, are reviewed. Fast neutrons were proven to be superior to photons for locally extended inoperable salivary gland tumours. The reported overall local control rates are 67 % and 24 % respectively. Paranasal sinuses and some tumours of the head and neck area, especially extended tumours with large fixed lymph nodes, are also indications for neutrons. By contrast, the results obtained for brain tumours were, in general, disappointing. Neutrons were shown to bring a benefit in the treatment of well differentiated slowly growing soft tissue sarcomas. The reported overall local control rates are 53 % and 38 % after neutron and photon irradiation respectively. Better results, after neutron irradiation, were also reported for bone- and chondrosarcomas. The reported local control rates are 54 % for osteosarcomas and 49 % for chondrosarcomas after neutron irradiation; the corresponding values are 21 % and 33 % respectively after photon irradiation. For locally extended prostatic adenocarcinoma, the superiority of mixed schedule (neutrons + photons) was demonstrated by a RTOG randomized trial (local control rates 77% for mixed schedule compared to 31 % for photons). Neutrons were also shown to be useful for palliative treatment of melanomas. Further studies are needed in order to definitively evaluate the benefit of fast neutrons for other localisations such as uterine cervix, bladder, and rectum.
    [Show full text]
  • Planning and Implementing a Swiss Radio-Oncology Network
    Chair Secretary PROTON Michael Goitein Ph. D. Daniel Miller Ph. D. THERAPY Department of Radiation Oncology Department of Radiation Medicine C O- Massachusetts General Hospital Loma Linda University Medical Center OPERATIVE Boston MA 02114 Loma Linda CA 92354 G ROUP (617) 724 - 9529 (909) 824 - 4197 (617) 724 - 9532 Fax (909) 824 - 4083 Fax ABSTRACTS of the XXIV PTCOG MEETING held in Detroit, Michigan, USA April 24-26 1996 1 INDEX Page PTCOG Focus Session I: Comparative treatment planning of nasopharyngeal tumors PTCOG nasopharynx treatment planning intercomparison. 5 A. Smith PTCOG Focus Session II: Proton theray clinical studies Proton therapy in 1996: a world wide perspective. 6 J. M. Sisterson Arteriovenous malformations: the NAC experience. 6 F. Vernimmen, J. Wilson, D. Jones, N. Schreuder, E. De Kock, J. Symons Preliminary results of carbon-ion therapy at NIRS. 6 H. Tsujii, J. Mizoe, T. Miyamoto, S. Morita, M. Mukai, T. Nakano, H. Kato, T. Kamada, K. Morita Proton radiation therapy for orbital and parameningeal rhabdomyosarcoma. 7 E. B. Hug, J.A. Adams, J. E. Munzenrider Conformal radiation therapy for retinoblastoma: comparison of various 3D proton plans. 8 M. Krengli, J. A Adams, E. B Hug PTCOG Focus Session III Radiotherapy in the treatment of prostate cancer: neutrons, protons or photons? An analysis of acute and late toxicity in a randomized study of pion vs. photon irradiation 9 for stage T3/4 prostate cancer. T. Pickles, G. Goodman, M. Dimitrov, G. Duncan, C. Fryer, P. Graham, M. McKenzie, J. Morris, D. Rheaume, I. Syndikus With conformal photon irradiation, who needs particles? 10 J.
    [Show full text]
  • Generation and Modeling of Radiation for Clinical and Research Applications Bishwambhar Sengupta Clemson University, [email protected]
    Clemson University TigerPrints All Dissertations Dissertations 8-2019 Generation and Modeling of Radiation for Clinical and Research Applications Bishwambhar Sengupta Clemson University, [email protected] Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations Recommended Citation Sengupta, Bishwambhar, "Generation and Modeling of Radiation for Clinical and Research Applications" (2019). All Dissertations. 2440. https://tigerprints.clemson.edu/all_dissertations/2440 This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by an authorized administrator of TigerPrints. For more information, please contact [email protected]. Generation and Modeling of Radiation for Clinical and Research Applications A Dissertation Presented to the Graduate School of Clemson University In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy Physics by Bishwambhar Sengupta August 2019 Accepted by: Dr. Endre Takacs, Committee Chair Dr. Delphine Dean Dr. Brian Dean Dr. Jian He Abstract Cancer is one of the leading causes of death in todays world and also accounts for a major share of healthcare expenses for any country. Our research goals are to help create a device which has improved accuracy and treatment times that will alleviate the resource strain currently faced by the healthcare community and to shed some light on the elementary nature of the interaction between ionizing radiation and living cells. Stereotactic radiosurgery is the treatment of cases in intracranial locations using external radiation beams. There are several devices that can perform radiosurgery, but the Rotating Gamma System is relatively new and has not been extensively studied.
    [Show full text]
  • Interactions of Particles and Matter, with a View to Tracking
    Interactions of particles and matter, with a view to tracking 2nd EIROforum School on Instrumentation, May 15th-22nd 2011, EPN science campus, Grenoble The importance of interactions Particles can interact with matter they traverse according to their nature and energy, and according to the properties of the matter being traversed. These interactions blur the trajectory and cause energy loss, but ... they are the basis for tracking and identification. In this presentation, we review the mechanisms that are relevant to present particle physics experiments. Particles we©re interested in Common, long-lived particles that high- energy experiments track and identify: gauge bosons: leptons: e±, µ±, , e µ hadrons: p, n, , K, ... Most are subject to electro-magnetic interactions (), some interact through the strong force (gluons), a few only feel the weak force (W±, Z). No gravity ... [Drawings: Mark Alford (0- mesons, ½+ baryons), ETHZ (bottom)] Energies that concern us The physics of current experiments may play in the TeV-EeV energy range. But detection relies on processes from the particle energy down to the eV ! [Top: LHC, 3.5+3.5 TeV, Bottom: Auger Observatory, > EeV] Interactions of neutrinos Neutrino interactions with matter are exceedingly rare. Interactions coming in 2 kinds: W± exchange: ªcharged currentº Z exchange: ªneutral currentº Typical reactions: - e n p e + e p n e ( discovery: Reines and Cowan, 1956) - + ± (in the vicinity of a nucleus, W or Z) - - e e (neutral current discovery, 1973) First neutral current event First neutral current event, seen in + the Gargamelle bubble chamber: e - - + - e e e e - One candidate found in 360,000 e anti-neutrino events.
    [Show full text]
  • Dosimetry and Radiation Quality in Fast- Neutron Radiation Therapy
    Linköping Studies in Health Sciences Thesis no. 989 Dosimetry and radiation quality in fast- neutron radiation therapy A study of radiation quality and dosimetric properties of fast-neutrons for external beam radiotherapy and problems associated with corrections of measured charged particle cross-sections by Jonas Söderberg Division of Radiation Physics, Department of Medicine and Care Faculty of Health Sciences, Linköping University SE-581 85 Linköping Sweden Linköping 2007 Dosimetry and radiation quality in neutron therapy ii Jonas Söderberg It is easier to perceive error than to find truth, for the former lies on the surface and is easily seen, while the latter lies in the depth, where few are willing to search for it. Johann Wolfgang von Goethe iii Dosimetry and radiation quality in neutron therapy iv Jonas Söderberg Dosimetry and radiation quality in fast-neutron radiation therapy - A study of radiation quality and basic dosimetric poperties of fast-neutrons for external beam radiotherapy and poblems associated with corrections of measured charged particle coss-sections by Jonas Söderberg Linköping Studies in Health Sciences Thesis no. 989 Akademisk avhandling som för avläggande av filosofie doktors examen vid Linköpings Universitetet kommer att offentligt försvaras i föreläsningssalen Conrad, Universitetssjukhuset i Linköping, onsdagen den 4 april 2007, klockan 9.00 Opponent: Docent Crister Ceberg, Lunds Universitet ISBN 978-91-85715-37-4 ISSN 0345-0082 Abstract The dosimetric poperties of fast-neutron beams with energies ≤80 MeV were explored using Monte Carlo techniques. Taking into account transport of all relevant types of released charged particles (electons, protons, deuteons, tritons, 3He and α particles) pencil-beam dose distributions were derived and used to calculate absorbed dose distributions.
    [Show full text]
  • Radium-Archiv
    246 Archivbehelf: Institut für Radiumforschung (XIII. Nachlaß Berta Karlik) XIII. NACHLASS „BERTA KARLIK“ Korrespondenzen Karton Fiche Aaserud, Finn – Kopenhagen; 1983 (1 Brief) 39 568 Abed-Navandy, Mohamed; 1967 (Empfehlungsschreiben) 39 568 Adler, Elfriede – Wien; 1955 (1 Brief) 39 568 Adloff, J. P., s. Getoff, Nikola Agathangelidis, A. – Thessaloniki; 1966 (2 Briefe) 39 568 Ageno, Mario, s. Rom, Istituto Superiore di Sanità Ahlften, Walter von – Hamburg; 1953, 1954 (2 Briefe) 39 568 Aiginger, Hans (Wien, Österreichische Hochschule, Atominstitut); 1972 (2 39 568 Briefe). Intus: Bericht an das Ministerium „Stellungnahme zum Projekt einer österreichischen Beteiligung an den Aktivitäten des SIN-Schweize- rischen Institutes für Nuklearforschung“ als Beilage Alaga, G., s. Paul, Helmut, u. Urban, Paul Albrecht, Wolfgang – Blindenmarkt; 1954, 1955 (2 Briefe) 39 568 Aldermaston/Berkshire, United Kingdom Atomic Energy Authority, 39 568 Atomic Weapons Research Establishment; 1959 (2 Briefe u. Empfangs- bestätigungen). Siehe auch Curran, S.C. Alexandria, University of Alexandria, Dean of the Faculty of Science; 1956 39 568 (1 Brief) Alm am Steinernen Meer, „Erholungsheim Gasteg-Alm“ u. Verein katho- 39 568 lischer Lehrerinnen für Österreich; 1961 (2 Briefe) Amersham/Buckinghamshire, United Kingdom Atomic Energy Authority, The Radiochemical Centre, s. Wien, Radio-Austria A.G.; Them. Korr., Wien, Österreichische Akademie der Wissenschaften, Institut für Radiumforschung, Isoto- penstelle, u. Them. Korr., Tritium Amon, Otto – Melk a. d. Donau; 1964 (1 Brief) 39 568 Archivbehelf: Institut für Radiumforschung (XIII. Nachlaß Berta Karlik) 247 Korrespondenzen Karton Fiche Amsterdam, Institut voor Kernphysisch Onderzoek, s. Aten, A. H. W. Jun; Bak- ker, C. J.; Wapstra, Aaldert H. Amsterdam, Joint Commission on Standard, s. Sizoo, G.
    [Show full text]
  • 1199 Radiation Therapy Clinical Guidelines Effective 07/01
    CLINICAL GUIDELINES Radiation Therapy Version 2.0.2019 Effective July 1, 2019 Clinical guidelines for medical necessity review of radiation therapy services. © 2019 eviCore healthcare. All rights reserved. Radiation Therapy Criteria V2.0.2019 Table of Contents Brachytherapy of the Coronary Arteries 6 Hyperthermia 15 Image-Guided Radiation Therapy (IGRT) 18 Neutron Beam Therapy 22 Proton Beam Therapy 24 Radiation Therapy for Anal Canal Cancer 66 Radiation Therapy for Bladder Cancer 69 Radiation Therapy for Bone Metastases 72 Radiation Therapy for Brain Metastases 77 Radiation Therapy for Breast Cancer 85 Radiation Therapy for Cervical Cancer 96 Radiation Therapy for Endometrial Cancer 103 Radiation Therapy for Esophageal Cancer 110 Radiation Therapy for Gastric Cancer 115 Radiation Therapy for Head and Neck Cancer 118 Radiation Therapy for Hepatobiliary Cancer 122 Radiation Therapy for Hodgkin’s Lymphoma 128 Radiation Therapy for Kidney and Adrenal Cancer 132 Radiation Therapy for Multiple Myeloma and Solitary Plasmacytomas 134 Radiation Therapy for Non-Hodgkin’s Lymphoma 138 Radiation Therapy for Non-malignant Disorders 143 Radiation Therapy for Non-Small Cell Lung Cancer 161 Radiation Therapy for Oligometastases 172 Radiation Therapy for Other Cancers 182 Radiation Therapy for Pancreatic Cancer 183 Radiation Therapy for Primary Craniospinal Tumors and Neurologic Conditions 189 Radiation Therapy for Prostate Cancer 197 Radiation Therapy for Rectal Cancer 206 Radiation Therapy for Skin Cancer 209 Radiation Therapy for Small Cell Lung Cancer 217 Radiation Therapy for Soft Tissue Sarcomas 220 Radiation Therapy for Testicular Cancer 226 Radiation Therapy for Thymoma and Thymic Cancer 229 Radiation Therapy for Urethral Cancer and Upper Genitourinary Tract Tumors 233 Radiation Treatment with Azedra 235 Radiation Treatment with Lutathera 238 Radioimmunotherapy with Zevalin 243 Selective Internal Radiation Therapy 254 ______________________________________________________________________________________________________ © 2019 eviCore healthcare.
    [Show full text]
  • Comments on Recent Measurements of the Stopping Power of Liquid Water
    Nuclear Instruments and Methods in Physics Research B 299 (2013) 51–53 Contents lists available at SciVerse ScienceDirect Nuclear Instruments and Methods in Physics Research B journal homepage: www.elsevier.com/locate/nimb Comments on recent measurements of the stopping power of liquid water ⇑ Rafael Garcia-Molina a, Isabel Abril b, Pablo de Vera b, Helmut Paul c, a Departamento de Física – Centro de Investigación en Óptica y Nanofísica, Universidad de Murcia, E-30100 Murcia, Spain b Departament de Física, Universitat d’Alacant, E-03080 Alacant, Spain c Atomic and Surface Science, University of Linz, Altenbergerstrasse 69, A 4040 Linz, Austria article info abstract Article history: Two experiments about the stopping power of liquid water for proton beams have recently been Received 16 November 2012 reported. The one by the Jyväskylä group (4.8–15.2 MeV) agrees nicely with the Bethe theory and other Received in revised form 2 January 2013 recent theoretical calculations, whereas the other one by the Kyoto group (0.3–2 MeV) appears to be Available online 8 February 2013 about 10% low. In this comment we show that the Kyoto energy spectra can be interpreted differently, so that the deduced stopping power also agrees with the Bethe stopping power. Keywords: Ó 2013 Elsevier B.V. All rights reserved. Stopping power Stopping force Energy loss of particles Liquid water Protons For medical physics, liquid water is one of the most important where S is the linear stopping power; Z2, A2 and q are the atomic substances. There are two recent experimental stopping power re- number, mass number and density of the target; Z1 and v are the sults of liquid water for swift protons: measurements by Shimizu atomic number and velocity of the projectile; b = v/c where c is et al.
    [Show full text]
  • Measurement of the Ni Directional Correlation with a Tunnel Diode
    . A MEASIBEMENT OP THE Ni^*^ DIE3CTI0NAL COHSELATION WITH A TUMT'RT. DIODE COUTGIDEHGE CIECUIT by GARY EDWIN CT.ARK « B. A., Park College, 1961 A MASTER'S THESIS submitted in partial fulfillment of the * requirements for the degree MASTER OP SCIENCE Department of Physics KANSAS STATE UNIVERSITY Manhattan, Kansas. 1966 Approved by; • Major Professor n C91 TABLE OF CONTENTS I. INTRODUCTION 1 1. Purpose of the Paper 1 2. Review of Literature 2 II. TUNNEL DIODE COINCIDENCE CIRCUIT ........ 3 1. Properties of the Tunnel Diode 3 2. The Univibrator Circuit 5 5. Detection of Coincident Pulses 9 4. Zero Crossover 10 5. Noise and Feedthrough ......... 11 6. Slewing 12 7. Effect of Temperature lA- 8. Jitter 14 9. Nanosecond Systems, Inc., Equipment . • 14 III. THEORY OP DIRECTIONAL CORRELATION 1? 1. The Directional Correlation Function . 17 2. The Ni60 Cascade 20 $. Analysis of Chance Rates 21 4. Experimental Considerations 24 5. Correction for Finite-Size Detectors . 27 IV. MEASUREMENT OF THE Ni^^ DIRECTIONAL CORRELATION 51 1. Apparatus 51 2. Determination of Resolving Times .... 52 5. Determination of Chance Rates 55 4. Determination of Correction for Finite- Size Detectors 54 5. Reduction of Error at 155° ....... 55 6. Analysis of Ni«^ Correlation Data ... 56 V. CONCLUSION , 41 VI. ACKNOWLEDGMENTS 42 VII. PLATES. 45 VIII . REFERENCES 75 I. INTRODUCTION 1. Purpose of the Paper In nuclear spectrometry scintillation materials and photo- multiplier tubes are frequently used which produce electrical pulses with two useful parameters, pulse height and time of occurrence. In this paper we are concerned with the second parameter and in particular a method of determining whether or not two pulses occur coincidently within a few nanoseconds (10"-' seconds) or less.
    [Show full text]